Kurz gefasst
Kommentar in der Zeitschrift Science, 2024. Verfasst von Haibo Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Dendritic Cells, Cellular Reprogramming, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Cancer cells reprogrammed into dendritic cells in vivo promote antitumor immunity
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Dendritic CellsCellular ReprogrammingNeoplasmsHumansAnimalsMice
Autor:innen und Institutionen
- Shanghai Institute of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Institute for Immunology, School of Basic Medical Sciences, Tsinghua University, Beijing, China.
- Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, China.
- Beijing Key Laboratory for Immunological Research on Chronic Diseases, Tsinghua University, Beijing, China.
Zitieren
APA
Zhou, H., & Wu, L. (2024). Reprogramming tumor cells to fight cancer. Science. https://doi.org/10.1126/science.ads6228
Vancouver
Zhou H, Wu L. Reprogramming tumor cells to fight cancer. Science. 2024. doi:10.1126/science.ads6228
BibTeX
@article{Zhou2024,
author = {Zhou, Haibo and Wu, Li},
title = {Reprogramming tumor cells to fight cancer},
journal = {Science},
year = {2024},
doi = {10.1126/science.ads6228}
}
EUVIMED